Meridian bioscience stock.

To view our range of antigens and antibodies for immunoassay development please visit our partner site meridianlifescience.comGet the latest stock quote, charts, news and analysis for Meridian Bioscience, Inc. (VIVO), a medical equipment company that develops diagnostic tests for various conditions. See the company's performance, earnings, acquisitions, acquisitions, and more on MarketScreener.The share price of Meridian Bioscience Inc. (VIVO) is $33.97 (NASDAQ) as of 30-Jan-2023 16:00 EST. Meridian Bioscience Inc. (VIVO) has given a return of 48.09% in the last 3 years.Meridian’s website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: mbi ...

Jan 31, 2023 · The estimated Net Worth of Catherine Sazdanoff is at least $365 ezer dollars as of 29 April 2016. Ms. Sazdanoff owns over 7,700 units of Meridian Bioscience stock worth over $261,569 and over the last 8 years she sold VIVO stock worth over $0. In addition, she makes $103,333 as Independent Director at Meridian Bioscience.Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) announces that effective today it will have completed the purchase of all the outstanding capital stock of the Bioline group of companies consisting of Bioline Ltd (UK), Bioline GmbH (Germany), Bioline (Aust) Pty Ltd (Australia), Bioline Reagents Ltd, and Bioline USA, Inc for $23.3 million in cash on hand.

Ms Lueke VIVO stock SEC Form 4 insiders trading. Ms has made over 4 trades of the Meridian Bioscience stock since 2012, according to the Form 4 filled with the SEC. Most recently she bought 4,000 units of VIVO stock worth $50,360 on 2 February 2017.. The largest trade she's ever made was exercising 21,000 units of Meridian …1 hour ago · 제목 : 에스디바이오센서(137310... ☞ 2023-11-22 종속회사 Columbus Holding Company, 발행회사의 인수금융 차입금 일부 상환을 위한 재원 제공 목적으로 Meridian Bioscience, Inc. 출자증권을 1,287.72억원에 취득하기로 결정(취득예정일:2023-11-30)

The stock of Meridian Bioscience (NAS:VIVO, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation.Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases.Meridian Bioscience has 5 employees across 11 locations and $333.02 m in ... Meridian Bioscience. Stock Price. $34. 2023-01-30. Market Capitalization. $1.5 B.Meridian’s website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: mbi ...The stock of Meridian Bioscience (NAS:VIVO, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation.

Meridian Bioscience Careers. Carrière. Benefits. Les avantages sociaux. Open Positions. Consulter les offres d'emploi. Life Science. Back; Products ... If the starting stock is a 25 mM solution of each dNTP in a 100mM dNTP Mix, you need to add 0.5 µL to a 50 µL standard PCR reaction.

The latest Meridian Bioscience stock prices, stock quotes, news, and VIVO history to help you invest and trade smarter.

Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected], Feb. 4, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2021.. First Quarter Fiscal 2022 ...Meridian Bioscience Stock Forecast and Price Target. According to experts, who recently provided their 2023 price targets for Meridian Bioscience, the average price target is $20.64, with a high estimate of $23.12 and a low estimate of $18.37. That is a potential upside of approximately 68,700% from the last closing price of $0.03 …SD Biosensor Inc (SDB) and SJL Partners LLC have agreed to acquire Meridian Bioscience Inc (NASDAQ:VIVO) in an all-cash transaction valued at approximately $1.53 billion.; Under the terms of the ...Legal Name Meridian Bioscience, Inc. Stock Symbol NASDAQ:VIVO. Company Type For Profit. Phone Number 5132725421. Meridian Bioscience is an integrated life science company. The Company is engaged in developing, manufacturing, selling, and distributing clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory, and parasitic ...Meridian Bioscience is a well-established global provider of innovative diagnostics products, covering the whole spectrum of services from manufacturing to marketing.

Curian is a rapid diagnostic solution for immunoassay detection of gastrointestinal diseases. It quickly and accurately identifies H. pylori, Campylobacter, and Shiga Toxin E. coli active infections. New tests are continuously being added to improve gastrointestinal outcomes and build a healthier community. As a publicly traded company, ownership of Meridian Bioscience, Inc. is constantly changing as shares are bought and sold on the stock market.Meridian Bioscience, Inc. (VIVO) Mission Statement The mission of Meridian Bioscience, Inc. is to provide diagnostic test kits, reagents, and related products and services that are of the highest quality ...Jan 31, 2023 · About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic products. Looking at the universe of stocks we cover at Dividend Channel, on 8/1/13, Meridian Bioscience Inc. (NASD: VIVO) will trade ex-dividend, for its quarterly dividend of $0.19, payable on 8/15/13. Meridian Bioscience Inc. (VIVO) Stock Price, News & Historical Data - TheStreet November 26, 2023 [ Healthcare ] [ Medical Diagnostics & Research ] [ VIVO ] Meridian Bioscience Inc. VIVO...Jan 31, 2023 · The estimated Net Worth of John P. Kenny is at least $17.5 Million dollars as of 24 June 2022. Mr Kenny owns over 74,996 units of Meridian Bioscience stock worth over $11,093,515 and over the last 5 years he sold VIVO stock worth over $4,939,280. In addition, he makes $1,508,705 as Pres and CEO & Director at Meridian Bioscience.

Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies ...Dec 12, 2022 · CINCINNATI, Dec. 12, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO ), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has ...

Meridian is an Ohio corporation and, therefore, governed by the corporate laws of Ohio. Since its stock is publicly traded on Nasdaq and it files reports with the Securities and Exchange Commission, it is also subject to NASD rules as well as various provisions of federal securities laws as recently changed by the Sarbanes-Oxley Act. Insiders trading at Meridian Bioscience. Over the last 21 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny, and John A Kraeutler.On average, Meridian Bioscience …7 juil. 2022 ... ... Meridian Bioscience Inc., a Nas. ... stock price on the day before the consortium's first offer before ...Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...The latest Meridian Bioscience stock prices, stock quotes, news, and VIVO history to help you invest and trade smarter. Meridian Bioscience is the IBD 50 Stocks To Watch pick for Wednesday as it eyes a new buy point and is forming a bullish base. It comes after VIVO stock ran as much as 456% above its 2020 lows. X ...

Meridian Bioscience (NASDAQ:VIVO) is a fully-integrated developer of diagnostic systems through its diagnostics segment, ... That means Meridian is a highly valued stock right now, ...

Jan 31, 2023 · The estimated Net Worth of James M. Anderson is at least 1.07 百万$ dollars as of 6 January 2023. Mr. Anderson owns over 8,500 units of Meridian Bioscience stock worth over 958,769$ and over the last 14 years he sold VIVO stock worth over 0$. In addition, he makes 114,667$ as Independent Director at Meridian Bioscience.

Dec 3, 2020 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ... Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, Inc. ("SDB") (KOSE: A137310) and SJL Partners ...Dive Brief: SD Biosensor said it’s postponing the closing date of its $1.53 billion merger with Meridian Bioscience to gain more time to complete financing. The deal now is scheduled to close on Jan. 31. Under the original terms, either party would have been able to terminate the deal if it was not consummated by Jan. 6.19 fév. 2020 ... pylori detection and is currently evaluating additional applications of the BreathID platform. Exalenz's shares are traded on the Tel Aviv Stock ...Meridian Bioscience announced July 7 it's entered into a definitive merger agreement to be acquired by a pair of South Korean-based firms, SD Biosensor and SJL Partners, in a deal valued at $1.53 ...Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has entered into a side letter with the buyer ...Dec 13, 2022 · A high-level overview of Meridian Bioscience, Inc. (VIVO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Jan 31, 2023 · The estimated Net Worth of James M. Anderson is at least 1.07 百万$ dollars as of 6 January 2023. Mr. Anderson owns over 8,500 units of Meridian Bioscience stock worth over 958,769$ and over the last 14 years he sold VIVO stock worth over 0$. In addition, he makes 114,667$ as Independent Director at Meridian Bioscience.Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...Check if VIVO Stock has a Buy or Sell Evaluation. VIVO Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Meridian Bioscience Inc. News.Meridian Bioscience has thrived during the COVID-19 pandemic. Can this stock go much higher, or is it time to cash out? Meridian Bioscience ( VIVO) ran past its 52-week high last week, closing on ...

Track Meridian Bioscience Inc. (VIVO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsMr. McIlwraith VIVO stock SEC Form 4 insiders trading. John has made over 6 trades of the Meridian Bioscience stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VIVO stock worth $37,950 on 25 February 2020.. The largest trade he's ever made was buying 5,000 units of Meridian Bioscience …Stock price history for Meridian Bioscience (VIVO) Highest end of day price: $35.90 USD on 2008-04-08. Lowest end of day price: $0.35 USD on 1987-12-08. Stock price history of Meridian Bioscience from 1986 to 2023. Stock price for similar companies or competitors. Company Stock priceMeridian’s stock soared 79% during that fiscal year. Newtown-based Meridian, founded in 1977, is Greater Cincinnati’s 16th-largest public company, according to Courier research. It reported ...Instagram:https://instagram. babcock and wilcox enterprisesforex broker us clientsschwab growth etfbest municipal bonds 2023 Sep 29, 2022 · Litigation Relating to the Merger. As previously disclosed, on July 7, 2022, Meridian Bioscience, Inc., a corporation organized under the laws of Ohio ("Meridian"), on the one hand, and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea, Columbus Holding Company, a corporation organized under the laws of Delaware ("Columbus Holding") and ... Meridian Bioscience is the IBD 50 Stocks To Watch pick for Wednesday as it eyes a new buy point and is forming a bullish base. It comes after VIVO stock ran as much as 456% above its 2020 lows. X ... wyndham hotels and resorts incmomentus inc. From a 100x stock, you need to add 0.5 µL to a 50 µL reaction. Meridian also offers more diluted mixes of 40mM total (10mM each), which is a 50x stock solution and 10 mM total (2.5 mM each) 10x working stock.Historical price to book ratio values for Meridian Bioscience Inc. (VIVO) over the last 10 years. The current price to book ratio for Meridian Bioscience Inc. as of November 29, 2023 is . Please refer to the Stock Price Adjustment Guide</a> for more information on our historical prices.</p> high beta etf Meridian Bioscience is the IBD 50 Stocks To Watch pick for Wednesday as it eyes a new buy point and is forming a bullish base. It comes after VIVO stock ran as much as 456% above its 2020 lows. X ...About Meridian. Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic and life science products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy, and simplicity that are redefining the possibilities of ...Meridian Bioscience Stock Hits New 52-Week High (VIVO) thestreet.com - March 26 at 5:22 PM Phoenix Union Bioscience High School usnews.com - March 23 at 3:29 PM Global "Diagnostics PCR Market" 2023: On-going Trends and Growth Insights by 2027 marketwatch.com - March 20 at 6:42 PM